NCT06302881 Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06287749 French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) Status RECRUITING Phase N/A
NCT06287463 Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway Status TERMINATED Phase PHASE1
NCT06276803 The LINFU® U.S. Registry for the in the General Population Without Risk Factors Status NOT_YET_RECRUITING Phase N/A
NCT06275737 POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric Status ACTIVE_NOT_RECRUITING Phase NA
NCT06219941 AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Status RECRUITING Phase PHASE2
NCT06218914 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06214533 Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery Status NOT_YET_RECRUITING Phase NA
NCT06199752 Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE4
NCT06168812 A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06151691 Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach Status NOT_YET_RECRUITING Phase N/A
NCT06151223 A Prospective Registry for Patients at High-Risk for Pancreatic Cancer Status RECRUITING Phase N/A
NCT06147037 A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06131840 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06128551 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06122896 Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals Status RECRUITING Phase EARLY_PHASE1
NCT06122480 Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma Status TERMINATED Phase NA
NCT06115499 The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06105021 Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06084481 Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 Status RECRUITING Phase PHASE1